News

Media And Political Bulletin – 12 May 2020

Media and Political Bulletin

12 May 2020

Government guidance published to help ensure workplaces are as safe as possible. The government, in consultation with industry, has published guidance to help employers, employees and the self-employed understand how to work safely during the coronavirus pandemic.

There are 8 guides, which cover a range of different types of work, notably:

  • Factories, plants and warehouses. Guidance for people who work in or run factories, plants and warehouses.
  • Vehicles. Guidance for people who work in or from vehicles, including couriers, mobile workers, lorry drivers, on-site transit and work vehicles, field forces and similar.
  • Offices and contact centres. Guidance for people who work in or run offices, contact centres and similar indoor environments.
  • Shops and branches. Guidance for people who work in or run shops, branches, stores or similar environments.

 

Media Summary

Ranitidine 50mg/2ml injection out of supply from May

Dispensing Doctors’ Association, Ailsa Colquhoun, 11 May 2020

Dispensing Doctors’ Association reports that Ranitidine 50mg/2ml injection is anticipated to be unavailable from the end of May 2020 until further notice. This is due to on-going regulatory investigations into the presence of the contaminant, N-nitrosodimethylamine (NDMA).

At present, in Europe all suppliers of Ranitidine’s active ingredient have had their Certificate of Suitability (CEP) suspended. Therefore, until regulatory investigations are complete, no further supplies of ranitidine products can be manufactured.

View the supply disruption alert for clinical advice on alternatives of ranitidine preparations for adults and children.

Parliamentary Coverage
 

There was no parliamentary coverage today.

 

Full Coverage

Ranitidine 50mg/2ml injection out of supply from May

Dispensing Doctors’ Association, Ailsa Colquhoun, 11 May 2020

Ranitidine 50mg/2ml injection is anticipated to be unavailable from the end of May 2020 until further notice. Ranitidine film-coated tablets, effervescent tablets and oral solution continue to remain unavailable with no date for resupply. This is due to on-going regulatory investigations into the presence of the contaminant, N-nitrosodimethylamine (NDMA). Clinical advice on alternatives of ranitidine preparations for adults and children has been shared in the previous supply disruption alert. View the alert.
Media And Political Bulletin – 12 May 2020
All Industry News

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?

Login